Tag: biomedical
-
Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis.
-
Early Trial Results Show Antibody Treating Covid-19
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days.
-
Precision Cancer Therapy Start-Up Gains $110M in Early Funds
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round.
-
Gilead Acquires Cancer Therapy Biotech for $21B
Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion.
-
NIH Trials Testing Covid-19 Blood Clot Therapies
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections.
-
Antibody Discovery Company Forms, Partners on Covid-19
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments.
-
Small Biz Grant Funds Covid-19 Disinfectant Spray
A Florida start-up company is developing a fast-acting disinfectant spray that dries on contact, yet still kills Covid-19 viruses on surfaces.
-
Digital Sedation Company Raises $11.8M in Early Funds
A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round.
-
Phone Data Show Stay-Home, Distancing Order Effects
Anonymous data collected from millions of mobile phones last spring show stay-at-home and social distancing orders helped slow the spread of Covid-19 in the U.S.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.